Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 44 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

37Total
Not Applicable (17)
P 1 (6)
P 2 (10)
P 3 (3)
P 4 (1)

Trial Status

Completed13
Recruiting13
Not Yet Recruiting7
Active Not Recruiting6
Enrolling By Invitation4
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT06628388Not ApplicableActive Not Recruiting

Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong

NCT06799637Phase 1Recruiting

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

NCT06919627CompletedPrimary

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

NCT06662435Not ApplicableCompleted

GYNecologic Cancer-Related COGnitive Impairment

NCT07038369Phase 1Active Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT06910657Phase 1Recruiting

IDOV-Immune for Advanced Solid Tumors

NCT06662136Not ApplicableCompletedPrimary

The Effect of Motivational Interviewing on HPV-DNA Testing

NCT06815939Not ApplicableRecruiting

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

NCT06796738Not ApplicableActive Not RecruitingPrimary

Advancing Cervical Cancer Screening Through the Emergency Department - IIS

NCT06727617Phase 2RecruitingPrimary

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

NCT06416696Phase 2Active Not RecruitingPrimary

Toripalimab for High-risk Locally Advanced Cervical Cancer

NCT06866951Phase 2WithdrawnPrimary

A Clinical Study Comparing Chemotherapy Combined With PD-1 Inhibitor Versus Concurrent Chemoradiotherapy in Cervical Cancer Patients With Positive Lymph Nodes After Surgery: A Multicenter Randomized Controlled Clinical Trial

NCT07273383Not ApplicableActive Not Recruiting

Self-sampling for HPV Screening

NCT06349148Not ApplicableRecruitingPrimary

The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients

NCT06925113CompletedPrimary

A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan

NCT06669533Not ApplicableRecruitingPrimary

Use Misoprostol to Optimize Prevention of Cervical Cancer

NCT06942286Not ApplicableEnrolling By InvitationPrimary

Primary HPV Self-Collection in Indonesia

NCT06958068Completed

Sexual Health Integration in Treatment of Gynecological Oncology

NCT07130240Phase 2RecruitingPrimary

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

NCT07093593Not ApplicableNot Yet RecruitingPrimary

Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs

Scroll to load more

Research Network

Activity Timeline